Photo of J.J. Kiladjian from vjhemonc.com
Aug 23, 2024, 14:01
J.J. Kiladjian: First European Use of Anti-Mutant CALR Bispecific Antibody for Myelofibrosis
J.J. Kiladjian, Professor of Clinical Pharmacology at Paris Diderot University, shared on X:
“Today at CIC Saint-Louis, a patient with myelofibrosis started for the 1st time in Europe a treatment with an anti-mutant CALR bispecific antibody.”
Source: J.J. Kiladjian/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 18, 2024, 16:11
Dec 18, 2024, 15:52
Dec 18, 2024, 15:49
Dec 18, 2024, 15:45
Dec 18, 2024, 15:38
Dec 18, 2024, 15:11
Dec 18, 2024, 15:08
Dec 18, 2024, 14:24
Dec 18, 2024, 14:21